Skip to main content

Animations

MJFF Publications

8121 - 8130 of 9030 Results
Title
Year
  • Year
  • 2025
  • 2022
  • 2021
  • 2010
  • 2024
  • 2024
  • 2016
  • 2022
  • 2026
  • 2025
  • Summary Details
    OPEN
    Title: Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s40478-025-01988-z
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.79771
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.1c00453
    Citation Count: 97
  • Summary Details
    OPEN
    Title: A comparative study of Lrrk2 function in primary neuronal cultures
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018
    Citation Count: 78
  • Summary Details
    OPEN
    Title: GBA 1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29753
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease
    Journal Name: Journal of Integrative Neuroscience
    Publisher: IMR Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.31083/j.jin2309178
    Citation Count: 4
  • Summary Details
    OPEN
    Title: LRRK2 variation and dementia with Lewy bodies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.07.015
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-Synuclein
    Journal Name: Analytical Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.analchem.2c03183
    Citation Count: 29
  • CSF LRRK2: A biomarker for slower autonomic dysfunction progression in sporadic Parkinson's disease
    2026
    Summary Details
    RESTRICTED
    Title: CSF LRRK2: A biomarker for slower autonomic dysfunction progression in sporadic Parkinson's disease
    Journal Name: Autonomic Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.autneu.2026.103399
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Classification of Parkinson’s disease and isolated REM sleep behaviour disorder: delineating progression markers from the sebum volatilome
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01026-8
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.